Today, the European Commission has proposed to subject the new psychoactive substance MDMB-CHMICA (sometimes referred to as ‘Black Mamba’) to control measures across the European Union.
According to the risk assessment report provided by EMCDDA, the acute toxicity of MDMB-CHMICA can cause severe harm to the health of individuals. So far, eight Member States have reported 28 deaths and 25 acute intoxications associated with MDMB-CHMICA. Multiple reports have also indicated the possibility that its use causes violence and aggression.
On the basis of the risk assessment report and following the proposal from the European Commission, the Council, having consulted the European Parliament, may decide to subject the drug to control measures throughout the EU. In such a case, EU Member States would then be required to introduce such controls in line with national laws no later than one year after the Council’s decision.
Click here to read the full article.
Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.